Related Experiment Video
Updated: May 16, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
A healthy nation: strengthening child health research in the UK
Neena Modi1, Howard Clark, Ingrid Wolfe
1Imperial College London, Chelsea and Westminster Hospital, London, UK. n.modi@imperial.ac.uk
Insights
Child health research in the UK faces significant challenges, including declining paediatrician numbers and underutilised National Health Service (NHS) potential. Improving research infrastructure, training, and funding is crucial for advancing child-specific treatments and future health outcomes.
Area of Science:
- Paediatric Research
- Health Services Research
- Biomedical Research
Background:
- Evidence base for child-specific treatments remains sparse despite acknowledged need.
- UK children's biomedical and health services research faces issues in training, infrastructure, activity, evidence, and visibility.
Purpose of the Study:
- To investigate the state of children's biomedical and health services research in the UK.
- To identify barriers and opportunities for improving research in child health.
Main Methods:
- Analysis of training programs, infrastructure, research activity, evidence generation, and visibility of children's research.
- Examination of National Health Service (NHS) recruitment rates and consultant time allocation for research.
- Review of funding allocation for child health research and paediatric representation on research boards.
Main Results:
- Decrease in academic paediatricians by 18% (2000-2011).
- Underutilisation of NHS potential for research: low recruitment (<2.5%), limited consultant research time (<5%), and inadequate research facilities in children's hospitals.
- Disparities in research support: strong for drug studies, inconsistent for non-drug research; only 5% of public/charitable biomedical research expenditure directed at child health.
Conclusions:
- UK Government commitment to biomedical research not fully translated to child health research.
- Scant evidence base impedes clinical guidance and policy development for children.
- Recommendations include multidisciplinary research groups, a unified Children's Research Network, improved training, and better integration with NHS activities.
Abstract:
Despite a general acknowledgment that research in children is necessary and ethical, the evidence base for child-specific treatments is still sparse. We investigated children's biomedical and health services research in the UK in relation to training, infrastructure and activity, research evidence, and visibility. We show that excellent opportunities for career researchers exist through a competitive, national integrated academic training programme, but that the number of academic paediatricians has decreased by 18% between 2000 and 2011, falling from 11·3% to 5·9% of the consultant workforce. The potential for rapid delivery of studies in children through the National Health Service (NHS) is not being realised: clinical trainees are poorly equipped with core research skills; most newly appointed consultant paediatricians have little or no research experience; less than 5% of contracted consultant time supports research; less than 2·5% of the 2 million children seen in the NHS every year are recruited to studies; and ten of the 20 UK children's hospitals do not have a clinical research facility. Support through National Institute for Health Research networks is good for studies into drugs, but inconsistent for non-drug research; less than 5% of registered studies involve children and only one children's biomedical research centre has been allocated funding from 2012. Of the UK annual public and charitable biomedical research expenditure of roughly £2·2 billion, about 5% is directed at child health research. The scant evidence base is impeding the development of clinical guidance and policy-less than 20% of the outputs of the National Institute for Health and Clinical Excellence are applicable to children. Paediatric representation on major research boards is weak. Parent and young people's advocacy is fragmented, and their views are insufficiently heeded by regulatory bodies. The strong UK Government commitment to biomedical research has not been translated fully to research for children. The power of research in children to turn the tide of the growing burden of non-communicable, chronic, adult diseases that have their origins in early life, to benefit the health of an ageing population and future generations, and to reduce health-care costs is inadequately recognised. On the basis of our findings, we make several recommendations to improve early-years research, including the formation of multidisciplinary, cross-institutional groups of clinical and non-clinical child health researchers and their access to diagnostic and laboratory facilities suitable for children; a unified Children's Research Network for drug studies and non-drug studies; regulatory assessment of research that is proportionate and based on consistent national criteria; an expansion of research posts; support for parents' and young people's advocacy; collaboration between children's research charities; improved research training for paediatric trainees; and closer integration of child health research with core NHS activities.
Related Concept Videos
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...

